A boxed warning regarding lactic acidosis was added to the label for Metformin Hydrochloride, effective 2026-05-27. This significant label revision highlights the risk of metformin-associated lactic acidosis, which has been linked to severe outcomes including death, hypothermia, hypotension, and resistant bradyarrhythmias. The onset of this condition is often subtle.
Background
The label update pertains to Metformin Hydrochloride, a medication that has been subject to postmarketing surveillance. The addition of a boxed warning indicates a serious safety concern identified from real-world cases. This type of warning is reserved for serious adverse reactions that can be prevented or mitigated by appropriate actions. The warning specifically addresses lactic acidosis, a known potential complication associated with metformin use.
What this means
The addition of a boxed warning for lactic acidosis to the Metformin Hydrochloride label on 2026-05-27 represents a critical safety update for healthcare providers and patients. This warning explicitly states that postmarketing cases of metformin-associated lactic acidosis have resulted in severe outcomes, including death, hypothermia, hypotension, and resistant bradyarrhythmias. The label emphasizes that the onset of metformin-associated lactic acidosis is often subtle, making early recognition challenging but crucial. Clinicians prescribing Metformin Hydrochloride must be vigilant for any signs or symptoms of lactic acidosis, such as malaise, myalgia, respiratory distress, somnolence, and abdominal distress. Patients should be educated on these symptoms and instructed to seek immediate medical attention if they experience them. This label change aims to enhance patient safety by ensuring that the serious and potentially fatal risks associated with Metformin Hydrochloride are prominently communicated, guiding more cautious prescribing practices and patient monitoring.
Source
This information was sourced from the FDA, specifically a label revision document for Metformin Hydrochloride, effective 2026-05-27. The details are available on the DailyMed website, hosted by nlm.nih.gov.